发明名称 Purinone derivative
摘要 <p>Disclosed is a compound represented by general formula (I) (wherein all the symbols are as defined in the description). Since the compound has excellent metabolic stability and is capable of avoiding hepatotoxicity or the like, while having Btk-selective inhibitory activity, the compound can form a safe therapeutic agent for diseases associated with B cells or mast cells.</p>
申请公布号 AU2011260961(B2) 申请公布日期 2015.02.05
申请号 AU20110260961 申请日期 2011.05.30
申请人 ONO PHARMACEUTICAL CO., LTD. 发明人 YAMAMOTO, SHINGO;YOSHIZAWA, TOSHIO
分类号 C07D473/34;A61K31/522;A61P7/02;A61P29/00;A61P35/00;A61P37/06;A61P43/00 主分类号 C07D473/34
代理机构 代理人
主权项
地址